Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Culig

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Prostate|February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markersJ Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis|January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinomaH Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer|September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.
The Prostate|March 1, 1996
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cellsM V Cronauer, H Klocker, H Talasz, et al.
Oncogene|October 31, 2006
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1I T Cavarretta, H Neuwirt, G Untergasser, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Oncogenesis|May 30, 2017
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signallingG Nappo, F Handle, F R Santer, et al.
The Journal of Urology|March 29, 2000
Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostateR Ischia, A Hobisch, R Bauer, et al.
Oncogene|August 11, 2015
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancerM Puhr, J Hoefer, A Eigentler, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Prostate|February 1, 1997
Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markersJ Zhang, M W Hess, M Thurnher, et al.
Urologia Internationalis|January 1, 1995
Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinomaH Klocker, F Neuschmid-Kaspar, Z Culig, et al.
British Journal of Cancer|September 25, 1999
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model systemZ Culig, J Hoffmann, M Erdel, et al.
The Prostate|March 1, 1996
Inhibitory effects of the nucleoside analogue gemcitabine on prostatic carcinoma cellsM V Cronauer, H Klocker, H Talasz, et al.
Oncogene|October 31, 2006
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1I T Cavarretta, H Neuwirt, G Untergasser, et al.
British Journal of Cancer|October 29, 1998
Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cellsZ Culig, A Hobisch, M Herold, et al.
The Prostate|June 1, 1997
Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostateM V Cronauer, A Hittmair, I E Eder, et al.
Oncogenesis|May 30, 2017
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signallingG Nappo, F Handle, F R Santer, et al.
The Journal of Urology|March 29, 2000
Elevated levels of serum secretoneurin in patients with therapy resistant carcinoma of the prostateR Ischia, A Hobisch, R Bauer, et al.
Oncogene|August 11, 2015
PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancerM Puhr, J Hoefer, A Eigentler, et al.
Pageof 6